CT Financial Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

CT Financial Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$5	Hold	8	–	–	﹤0.01%	643
2016 Q4	$6	Hold	8	–	–	﹤0.01%	640
2016 Q3	$7	Sell	8 -19	-70%	-$10	﹤0.01%	637
2016 Q2	$13	Hold	27	–	–	﹤0.01%	640
2016 Q1	$17	Hold	27	–	–	﹤0.01%	629
2015 Q4	$32	Hold	27	–	–	﹤0.01%	633
2015 Q3	$23	Hold	27	–	–	﹤0.01%	643
2015 Q2	$31	Sell	27 -13	-33%	-$25	﹤0.01%	631
2015 Q1	$80	Hold	40	–	–	﹤0.01%	618
2014 Q4	$42	Buy	+40	New	+$43	﹤0.01%	521

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

CT Financial Advisors's BTX.WS Position: Q1 2017 in Review

CT Financial Advisors held its BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) position steady in Q1 2017 at 8 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #643.

CT Financial Advisors first reported a position in BTX.WS in Q4 2014 and has held it in 10 quarters since. The position peaked at $80 in Q1 2015. 37 funds tracked by Wall St. Rank hold BTX.WS as of Q1 2017.

CT Financial Advisors held 8 shares of BioTime Inc Warrants (Expiring October 1, 2018) worth $5 as of Q1 2017.
CT Financial Advisors left its BioTime Inc Warrants (Expiring October 1, 2018) share count unchanged in Q1 2017.
BioTime Inc Warrants (Expiring October 1, 2018) made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #643 holding.
CT Financial Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and has held it in 10 quarters since.
CT Financial Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $80 in Q1 2015.
37 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.